A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee

Summary

This is a Phase 2 study, involving a 4-week treatment period, designed to test the ability of investigational study drug ARRY-371797 to reduce pain in patients with moderate to severe pain due to osteoarthritis (OA) of the knee, and to further evaluate the drug's safety. Approximately 150 patients from the US will be enrolled in this study.

Timeline

Start

2011-06

Primary completion

2012-06

Completion

2012-06

Drugs

Indications